NCT04711863: Fluvoxamine for Adults With Mild to Moderate COVID-19
- State
- Suspended
- Phase
- Phase 2
- People
- 400 planned
- Started
- 16 Jan 2021
- Primary completion
- 31 May 2021
- Arms
- Fluvoxamine
- Results
- None posted
- 15 Jan 2021: Trial registered
- 16 Jan 2021: Trial started
- 19 Apr 2021: Trial suspended